4//SEC Filing
VERTEX PHARMACEUTICALS INC / MA 4
Accession 0001209191-14-075834
$VRTXCIK 0000875320operating
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:06 PM ET
Size
7.6 KB
Accession
0001209191-14-075834
Insider Transaction Report
Form 4
Connolly Thomas
SVP, Human Resources
Transactions
- Sale
Common Stock
2014-12-12$119.73/sh−300$35,919→ 34,595 total - Sale
Common Stock
2014-12-12$120.50/sh−220$26,510→ 34,375 total
Holdings
- 150(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $119.73 (range $119.31 to $120.25).
- [F3]Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $120.50 (range $120.45 to $120.57).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000875320
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:06 PM ET
- Size
- 7.6 KB